Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
19.93
+0.57 (2.94%)
At close: May 12, 2025, 4:00 PM
19.78
-0.15 (-0.75%)
After-hours: May 12, 2025, 4:05 PM EDT
Genmab Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 21,638 | 21,526 | 16,474 | 14,505 | 8,417 | 10,111 | Upgrade
|
| Revenue Growth (YoY) | 51.92% | 30.67% | 13.58% | 72.33% | -16.75% | 88.43% | Upgrade
|
| Cost of Revenue | 1,000 | 985 | 226 | - | - | - | Upgrade
|
| Gross Profit | 20,638 | 20,541 | 16,248 | 14,505 | 8,417 | 10,111 | Upgrade
|
| Selling, General & Admin | 3,791 | 3,790 | 3,297 | 2,676 | 1,283 | 661 | Upgrade
|
| Research & Development | 9,696 | 9,672 | 7,630 | 5,562 | 4,181 | 3,137 | Upgrade
|
| Operating Expenses | 13,487 | 13,462 | 10,927 | 8,238 | 5,464 | 3,798 | Upgrade
|
| Operating Income | 7,151 | 7,079 | 5,321 | 6,267 | 2,953 | 6,313 | Upgrade
|
| Interest Expense | -121 | -120 | -70 | -39 | -13 | -10 | Upgrade
|
| Interest & Investment Income | 982 | 995 | 982 | 324 | 197 | 184 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,304 | 1,339 | -889 | 1,051 | 1,470 | -1,456 | Upgrade
|
| EBT Excluding Unusual Items | 9,316 | 9,293 | 5,344 | 7,603 | 4,607 | 5,031 | Upgrade
|
| Merger & Restructuring Charges | -300 | -300 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 219 | 247 | 293 | -658 | -689 | 873 | Upgrade
|
| Asset Writedown | -76 | -76 | - | - | - | - | Upgrade
|
| Pretax Income | 9,159 | 9,164 | 5,637 | 6,945 | 3,918 | 5,904 | Upgrade
|
| Income Tax Expense | 1,312 | 1,320 | 1,285 | 1,493 | 961 | 1,146 | Upgrade
|
| Net Income | 7,847 | 7,844 | 4,352 | 5,452 | 2,957 | 4,758 | Upgrade
|
| Net Income to Common | 7,847 | 7,844 | 4,352 | 5,452 | 2,957 | 4,758 | Upgrade
|
| Net Income Growth | 81.06% | 80.24% | -20.18% | 84.38% | -37.85% | 119.67% | Upgrade
|
| Shares Outstanding (Basic) | 64 | 64 | 65 | 65 | 65 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 64 | 65 | 66 | 66 | 66 | 66 | Upgrade
|
| Shares Change (YoY) | -2.27% | -1.94% | -0.14% | -0.06% | 0.24% | 3.53% | Upgrade
|
| EPS (Basic) | 122.80 | 122.21 | 66.64 | 83.38 | 45.22 | 73.00 | Upgrade
|
| EPS (Diluted) | 122.05 | 121.36 | 66.02 | 82.59 | 44.77 | 72.21 | Upgrade
|
| EPS Growth | 85.27% | 83.82% | -20.06% | 84.48% | -38.00% | 112.19% | Upgrade
|
| Free Cash Flow | 7,644 | 7,584 | 7,014 | 3,595 | 1,976 | 6,126 | Upgrade
|
| Free Cash Flow Per Share | 118.90 | 117.34 | 106.41 | 54.46 | 29.92 | 92.98 | Upgrade
|
| Gross Margin | 95.38% | 95.42% | 98.63% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | 33.05% | 32.89% | 32.30% | 43.21% | 35.08% | 62.44% | Upgrade
|
| Profit Margin | 36.27% | 36.44% | 26.42% | 37.59% | 35.13% | 47.06% | Upgrade
|
| Free Cash Flow Margin | 35.33% | 35.23% | 42.58% | 24.79% | 23.48% | 60.59% | Upgrade
|
| EBITDA | 7,464 | 7,390 | 5,529 | 6,555 | 3,147 | 6,543 | Upgrade
|
| EBITDA Margin | 34.49% | 34.33% | 33.56% | 45.19% | 37.39% | 64.71% | Upgrade
|
| D&A For EBITDA | 313 | 311 | 208 | 288 | 194 | 230 | Upgrade
|
| EBIT | 7,151 | 7,079 | 5,321 | 6,267 | 2,953 | 6,313 | Upgrade
|
| EBIT Margin | 33.05% | 32.89% | 32.30% | 43.21% | 35.08% | 62.44% | Upgrade
|
| Effective Tax Rate | 14.32% | 14.40% | 22.80% | 21.50% | 24.53% | 19.41% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.